A Fruit and Vegetable Prescription Program
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorMilton S. Hershey Medical Center
About this trial
Dietary intake of fruits and vegetables (F\&V) is a cornerstone for the treatment of type 2 diabetes, however less than 16% of Hispanic adults consume the recommended number of servings each day. F\&V prescription (F\&V Rx) programs are embedded into clinical settings and provide patients with vouchers to purchase F\&V at local retailers. The proposed study aims to test the effects of a F\&V Rx on diabetes self-management education and support (DSME/S) uptake and retention, dietary intake of F\&V and diet quality, glucose control (hemoglobin A1c), and program implementation outcomes.
Eligibility criteria
Qualifiers
Patient at Penn State Health St. Joe's Medical Center
Diagnosis of Type 2 Diabetes Mellitus greater than or equal to six months
A1c level is greater than or equal to 7% (53 mmol/mol)
Low income defined as enrolled in Supplemental Nutrition Assistance Program (SNAP), is uninsured or have Medicaid, or identifying as food insecure based on USDA criteria.
Disqualifiers
Diagnosis of Type 2 Diabetes Mellitus less than six months
Patients who have previously participated in the Veggie Rx program in the past year
Patients who have attended any diabetes self-management education and support (DSME/S) sessions in the past year
Women who are pregnant or who plan to become pregnant during the study period
Trial design
Treatments tested in this trial
- Usual Care
- F&V Rx alone
- F&V Rx plus DSME/S
Treatment groups
120 Participants
are divided into 3 treatment groupsLocations
1Penn State Health St. Joseph Downtown Campus19601, ReadingPennsylvania, United States
Sponsors and collaborators
Milton S. Hershey Medical Center
Lead sponsor
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Collaborator
Source ClinicalTrials.gov